Why the study?
Does the choice of anticoagulant (heparin vs citrate) and membrane material (CA vs PVC) affect biocompatibility during membrane plasmapheresis in a patient with myasthenia gravis?
Population
26 year old male with myasthenia gravis (n=1)
Comparison
Membrane plasma exchange using cellulose… vs Different combinations of membrane material and…
Design
Case_report
Authors
Loading...
Citrate with PVC may improve biocompatibility in plasmapheresis; hypothesis-generating from single case and needs prospective validation.
Does the choice of anticoagulant (heparin vs citrate) and membrane material (CA vs PVC) affect biocompatibility during membrane plasmapheresis in a patient with myasthenia gravis?
In a single-patient case report of membrane plasmapheresis, citrate anticoagulation with a PVC membrane demonstrated better biocompatibility than heparin with a cellulose di-acetate membrane.
Omokawa et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: